sST2 Predicts Short Term Therapy Success in Patients with Therapy Resistant Hypertension after Renal Sympathetic Denervation

sST2 Predicts Short Term Therapy Success in Patients with Therapy Resistant Hypertension after Renal Sympathetic Denervation

Background: Renal sympathetic denervation (RSD) has provided promising data in its ability to treat therapy resistant arterial hypertension. The effect of RSD on sST-2, a promising biomarker for risk stratification in cardiovascular diseases, has so far not been systematically studied. Methods: We e...

Full description

Bibliographic Details
Main Authors: Albert Topf, Vera Paar, Janine Grueninger, Bernhard Wernly, Kristen Kopp, Thomas Weber, Christiana Schernthaner, Moritz Mirna, Sarah X. Gharibeh, Robert Larbig, Rudin Pistulli, Uta C. Hoppe, Michael Lichtenauer, Lukas J. Motloch, Mathias C. Brandt
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Applied Sciences
Subjects:
resistant arterial hypertension
renal denervation
sST2
Online Access:https://www.mdpi.com/2076-3417/11/23/11130

Similar Items

Similar Items